EDGAR Filing Documents for 0001564590-18-020775

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001564590-18-020775

Filing Date

2018-08-09

Accepted

2018-08-09 08:43:28

Documents

Period of Report

2018-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	jnp-10q_20180630.htm	10-Q	2750195
2	EX-10.1	jnp-ex101_208.htm	EX-10.1	153650
3	EX-10.2	jnp-ex102_209.htm	EX-10.2	443702
4	EX-10.3	jnp-ex103_210.htm	EX-10.3	271083
5	EX-31.1	jnp-ex311_10.htm	EX-31.1	8781
6	EX-31.2	jnp-ex312_9.htm	EX-31.2	8719
7	EX-32.1	jnp-ex321_7.htm	EX-32.1	5824
8	EX-32.2	jnp-ex322_6.htm	EX-32.2	6081
	Complete submission text file	0001564590-18-020775.txt		10076328

Data Files

Seq	Description	Document	Type	Size
9	XBRL INSTANCE DOCUMENT	jnp-20180630.xml	EX-101.INS	2153674
10	XBRL TAXONOMY EXTENSION SCHEMA	jnp-20180630.xsd	EX-101.SCH	55387
11	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	jnp-20180630_cal.xml	EX-101.CAL	67182
12	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	jnp-20180630_def.xml	EX-101.DEF	192868
13	XBRL TAXONOMY EXTENSION LABEL LINKBASE	jnp-20180630_lab.xml	EX-101.LAB	412722
14	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	jnp-20180630_pre.xml	EX-101.PRE	327288

Mailing Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110

Business Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110 617-639-1500

JUNIPER PHARMACEUTICALS INC (Filer) CIK: 0000821995 (see all company filings)